- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Hyperkalaemia
- Meeting Date: November 2019
- Public Summary Document (PSD) November 2019 PBAC Meeting - (PDF 706KB)
- Public Summary Document (PSD) November 2019 PBAC Meeting - (Word 181KB)
Patiromer – November 2019
Patiromer: Powder for oral liquid 8.4 g, Powder for oral liquid 16.8 g; Veltassa®
Last updated
20 March 2020